97 related articles for article (PubMed ID: 29984481)
1. Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) study.
Ishii Y; Fujisawa S; Ando T; Suzuki T; Ishiyama Y; Kishimoto K; Hattori Y; Nakajima Y; Miyazaki T; Takasaki H; Matsumoto K; Koharazawa H; Taguchi J; Fujimaki K; Sakai R; Nakajima H
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e455-e459. PubMed ID: 29984481
[TBL] [Abstract][Full Text] [Related]
2. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
4. Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation therapy.
Stroh EL; Besa PC; Cox JD; Fuller LM; Cabanillas FF
Cancer; 1995 May; 75(9):2392-9. PubMed ID: 7712450
[TBL] [Abstract][Full Text] [Related]
5. Patients with primary diffuse large B-cell lymphoma of female genital tract have high risk of central nervous system relapse.
Cao XX; Li J; Zhang W; Duan MH; Shen T; Zhou DB
Ann Hematol; 2014 Jun; 93(6):1001-5. PubMed ID: 24408160
[TBL] [Abstract][Full Text] [Related]
6. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma].
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Ma XL; Zhang YH
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):748-753. PubMed ID: 29050112
[No Abstract] [Full Text] [Related]
8. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
9. [Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].
Huang HQ; Peng YL; Lin XB; Sun XF; Lin TY; Xia ZJ; Li YH; Cai QQ; He YJ; Jiang WQ; Guan ZZ
Ai Zheng; 2004 Nov; 23(11 Suppl):1443-7. PubMed ID: 15566653
[TBL] [Abstract][Full Text] [Related]
10. Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases.
Harris NL; Scully RE
Cancer; 1984 Jun; 53(11):2530-45. PubMed ID: 6585265
[TBL] [Abstract][Full Text] [Related]
11. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
12. Primary breast lymphoma.
Gholam D; Bibeau F; El Weshi A; Bosq J; Ribrag V
Leuk Lymphoma; 2003 Jul; 44(7):1173-8. PubMed ID: 12916870
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
14. Primary stage I-IIE non-Hodgkin's lymphoma of uterine cervix and upper vagina: evidence for a conservative approach in a study on three patients.
Garavaglia E; Taccagni G; Montoli S; Panacci N; Ponzoni M; Frigerio L; Mangili G
Gynecol Oncol; 2005 Apr; 97(1):214-8. PubMed ID: 15790461
[TBL] [Abstract][Full Text] [Related]
15. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K
Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782
[TBL] [Abstract][Full Text] [Related]
16. Primary malignant lymphoma of uterine corpus: case report and review of the literature.
Renno SI; Moreland WS; Pettenati MJ; Beaty MW; Keung YK
Ann Hematol; 2002 Jan; 81(1):44-7. PubMed ID: 11807635
[TBL] [Abstract][Full Text] [Related]
17. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in China: a 10-year retrospective follow-up analysis of 437 cases from Shanghai Lymphoma Research Group.
Li X; Liu Z; Cao J; Hong X; Wang J; Chen F; Wang C; Zou S; Li J; Shen Z
Ann Hematol; 2012 Jun; 91(6):837-45. PubMed ID: 22160255
[TBL] [Abstract][Full Text] [Related]
18. Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) Study.
Cai L; Stauder MC; Zhang YJ; Poortmans P; Li YX; Constantinou N; Thariat J; Kadish SP; Nguyen TD; Kirova YM; Ghadjar P; Weber DC; Bertran VT; Ozsahin M; Mirimanoff RO
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):284-91. PubMed ID: 22079728
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of anaplastic large-cell lymphoma in children and adolescents: a retrospective multicenter survey study].
;
Zhonghua Er Ke Za Zhi; 2017 Mar; 55(3):194-199. PubMed ID: 28273702
[No Abstract] [Full Text] [Related]
20. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
